United Capital Management Of Ks, Inc. Eli Lilly & CO Transaction History

United Capital Management Of Ks, Inc.

$404 Million
Q3 2024

A detailed history of United Capital Management Of Ks, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, United Capital Management Of Ks, Inc. holds 12,233 shares of LLY stock, worth $9.15 Million. This represents 2.68% of its overall portfolio holdings.

Number of Shares

12,233

Previous 12,239 0.05%

Holding current value

$9.15 Million

Previous $11.1 Million 2.19%

% of portfolio

2.68%

Previous 2.64%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$772.14 - $960.02 $4,632 - $5,760	-6 Reduced 0.05%	12,233 $10.8 Million
Q2 2024 Jul 30, 2024	SELL	$724.87 - $909.04 $23,920 - $29,998	-33 Reduced 0.27%	12,239 $11.1 Million
Q1 2024 Apr 19, 2024	SELL	$592.2 - $792.28 $59,220 - $79,228	-100 Reduced 0.81%	12,272 $9.55 Million
Q4 2023 Jan 25, 2024	SELL	$525.19 - $619.13 $193,269 - $227,839	-368 Reduced 2.89%	12,372 $7.21 Million
Q3 2023 Nov 03, 2023	BUY	$434.7 - $599.3 $3.41 Million - $4.7 Million	7,846 Added 160.32%	12,740 $6.84 Million
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $101,714 - $136,004	-290 Reduced 5.59%	4,894 $2.3 Million
Q1 2023 Apr 27, 2023	SELL	$310.63 - $364.82 $122,698 - $144,103	-395 Reduced 7.08%	5,184 $1.78 Million
Q4 2022 Jan 31, 2023	SELL	$321.55 - $374.67 $93,249 - $108,654	-290 Reduced 4.94%	5,579 $2.04 Million
Q3 2022 Oct 31, 2022	SELL	$296.48 - $337.87 $37,060 - $42,233	-125 Reduced 2.09%	5,869 $1.9 Million
Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $174,763 - $205,198	-627 Reduced 9.47%	5,994 $1.94 Million
Q1 2022 Apr 26, 2022	SELL	$234.69 - $291.66 $32,387 - $40,249	-138 Reduced 2.04%	6,621 $1.9 Million
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $24,058 - $29,857	107 Added 1.61%	6,759 $1.87 Million
Q3 2021 Oct 27, 2021	SELL	$221.6 - $272.71 $63,820 - $78,540	-288 Reduced 4.15%	6,652 $1.54 Million
Q2 2021 Jul 26, 2021	BUY	$180.55 - $233.54 $42,609 - $55,115	236 Added 3.52%	6,940 $1.59 Million
Q1 2021 Apr 27, 2021	SELL	$164.32 - $212.72 $17,253 - $22,335	-105 Reduced 1.54%	6,704 $1.25 Million
Q4 2020 Jan 21, 2021	BUY	$130.46 - $172.63 $26,613 - $35,216	204 Added 3.09%	6,809 $1.15 Million
Q3 2020 Oct 19, 2020	BUY	$146.22 - $169.13 $103,377 - $119,574	707 Added 11.99%	6,605 $977,000
Q2 2020 Jul 17, 2020	BUY	$136.42 - $164.18 $47,064 - $56,642	345 Added 6.21%	5,898 $968,000
Q1 2020 May 04, 2020	BUY	$119.05 - $147.35 $30,357 - $37,574	255 Added 4.81%	5,553 $770,000
Q4 2019 Jan 24, 2020	BUY	$106.92 - $132.43 $58,164 - $72,041	544 Added 11.44%	5,298 $696,000
Q3 2019 Oct 15, 2019	BUY	$106.79 - $116.16 $24,668 - $26,832	231 Added 5.11%	4,754 $513,000
Q2 2019 Jul 25, 2019	BUY	$110.79 - $129.32 $16,840 - $19,656	152 Added 3.48%	4,523 $510,000
Q1 2019 May 01, 2019	BUY	$111.31 - $131.02 $49,644 - $58,434	446 Added 11.36%	4,371 $516,000
Q4 2018 Jan 10, 2019	BUY	$105.9 - $118.64 $415,657 - $465,662	3,925 New	3,925 $454,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Management Of Ks, Inc., based on Form 13F filings with the SEC.

News

Stay updated on United Capital Management Of Ks, Inc. with notifications on news.

Account

United Capital Management Of Ks, Inc. Eli Lilly & CO Transaction History